>> HOME > Info
September 2009-
Candela GentleMax tratment of the week
The GentleMAX received national recognition as the Sunday Express treatment of the week. On 27th September 2009 Candela dual wavelength Laser got voted treatment of the week for its comprehensive hair removal treatment. The GentleMAX has ND:YAG and Alexandrite wavelengths both Gold standard technology for permanent hair reduction on skin of any colour. The GentleMAX is one of the most powerful and versatile lasers on the market, with inbuilt Dynamic Cooling Device (DCD) for the protection of the epidermis rather than just patient comfort. It is this unique technology that makes the Candela GentleMAX the safest and most effective laser for permanent hair reduction.
May 2009-
STUDIES HIGHLIGHT A REVOLUTIONARY NEW METHOD OF TREATING POST-OPERATIVE BRUISING
Candela's Vbeam Laser Gives Millions of Post-Surgical Patients a New Sense of Freedom
WAYLAND, MA – May 27, 2009 – Candela Corporation (NASDAQ: CLZR) announced today that two studies have reported superior results on patients who benefited from the Candela Vbeam® laser treatments for bruising resulting from cosmetic procedures. The studies concluded that the Vbeam pulsed-dye laser significantly expedited the healing process, improved outcomes, and provided greater overall patient satisfaction.
A study published in the March/April 2009 edition of the Archives of Facial Plastic Surgery, entitled: “Pulsed-Dye Laser for Treating Ecchymoses After Facial Cosmetic Procedures” by DeFatta, R. J., Krishna, S., and Williams, E. F., III concluded that “the Vbeam laser treatment resulted in a 63% mean improvement in ecchymoses scores within forty-eight (48) to seventy-two (72) hours.”
The second study, a 2009 ASLMS abstract, entitled: “A Simple Solution to a Common Problem” evaluated the effectiveness and safety of the long-pulse PDL (the Vbeam) for the treatment of ecchymoses. In this study by Elizabeth Hale, M.D., Julie Karen, M.D., Chris Hunzeker, M.D., Elliot Weiss, M.D., Leonard Bernstein, M.D., Lori Brightman, M.D., Anne Chapas, M.D., and Roy Geronemus, M.D. results showed that twenty-four hours post-treatment with the Vbeam laser, the average improvement was 62% and 13% for treated and untreated bruises, respectively.
Edwin F. Williams, M.D., Director, The Williams Center Plastic Surgery Specialists, and nationally recognized plastic surgeon pioneered this breakthrough Vbeam treatment. “Anytime you penetrate the skin there is a potential for bruising and we find that it is the bruising which occurs after many of these procedures that prevents patients from getting out into the public. It is extremely difficult to cover these unsightly marks with make-up and bruising can last for a number of weeks,” said Dr. Williams. Dr. Williams continued, “After just one treatment with the Vbeam, our patients experience dramatic clearance of the injured blood vessels. This treatment is a significant differentiator to our practice and we are excited to finally be able to offer our patients a safe and easy treatment of bruising that works!”
Roy G. Geronemus, M.D., Director, Laser & Skin Surgery Center of New York, commented, “There are millions of surgical and injectable procedures performed every year which often have bruising as a side effect that can last up to two weeks.” Dr. Geronemus continued, “This is a significant new use for the Vbeam which was already our “workhorse” laser because of its efficacy and safety profile for a wide variety of applications including skin rejuvenation, the treatment of rosacea, acne, diffuse redness, scars and more.”
For more information on the Vbeam click here or call 0845 521 0698
February 2009-
CANDELA INTRODUCES THE QUADRALASE SYSTEM TAKING FRACTIONAL CO2 THERAPY TO THE NEXT LEVEL
New Revenue Stream for Practitioners Around the World Performance, Versatility and Value in One Device
WAYLAND, MA, February 11, 2009 -- Candela Corporation (NASDAQ:CLZR) announced today the introduction of the new QuadraLASE™ laser. The QuadraLASE system combines the proven performance of a CO2 laser with an innovative scanning system giving practitioners a total solution for skin rejuvenation* and tightening** by treating wrinkles, uneven tone and texture, sun damage, acne scarring, the removal of skin tags, benign lesions and more. The Company will begin sales and marketing activities around the world with launch at the Annual Meeting of the American Academy of Dermatology, which takes place in San Francisco from March 6-10, 2009, and will commence shipments in March.
The QuadraLASE system utilizes the unique patent pending QuadraSCAN™ technology, which minimizes heat build-up in the skin, resulting in increased patient comfort. In addition, the system is engineered to fit the needs of every aesthetic practice offering:
- Value with no disposables – keeping long-term operating costs down.
- Choice of QS and QD handpieces providing true variable depth ablation.
- Elegant design and small footprint minimizing the need for space.
- Renowned Candela after-the-sale support.
“We are excited to be offering a unique solution for fractional ablation, one of the fastest growing segments of the aesthetic market,” said Catherine A. Kniker, Senior Vice President of Marketing and Corporate Development. “We recognized the restrictions of fractional lasers and are now offering our QuadraLASE system to deliver a more desirable experience to patients and physicians. This advanced skin rejuvenation device will bring a whole new dimension to aesthetic medicine allowing practitioners to diversify treatment capabilities with a single device.”
Kniker continued, “Candela has consistently developed gold standard products to treat the most popular applications, including leg and facial vein removal, skin rejuvenation and tightening, permanent hair reduction, tattoo and pigmented lesion removal and acne reduction. With the QuadraLASE system joining our suite of lasers, we now have the most comprehensive best-in-class solutions in the market.”
Thomas E. Rohrer, M.D., SkinCare Physicians of Chestnut Hill (MA), who performed some of the studies, stated, “Based on my clinical experience with the QuadraLASE system, this device is very versatile, easy-to-use and comfortable for the patient, and it delivers excellent results.”
About QuadraLASE: The new QuadraLASE fractional laser features proprietary QuadraSCAN technology, which reduces heat build-up in the skin, resulting in increased patient comfort. Candela QuadraLASE offers performance, versatility and value in a fractional CO2 laser. For more information please visit www.quadralase.com or call 0845 521 0698
* Skin rejuvenation through skin resurfacing.
** Skin tightening through wrinkle reduction.
QuadraLASE and QuadraSCAN are trademarks, and Candela is a registered trademark of Candela Corporation.
Request more information
Request more information
June 2008-
CANDELA launch innovative device for pain reduction
At this year’s British Medical Laser Association annual meeting Candela UK introduced their revolutionary new device for the management of pain during Laser and IPL treatments. The Serenity Pro System is an innovative approach for reducing pain during aesthetic laser or IPL treatments. Suitable for all laser and IPL systems the Serenity Pro relies on Pneumatic Skin Flattening technology (PSF™) and is based on the principle of the “gate theory”. PSF works by creating a vacuum through a chamber that pushes blood away from the treatment site and blocks pain signals to the brain. This has a dual effect of reducing pain and improving efficacy of many treatments.
Reducing Pain
The pain reduction is a result of the “gate theory”. Very simply this is based on the fact that you can only feel one sensation at a time, if suction (pressure) is applied to the target area immediately before the energy is applied the treatment pain is not registered.
Better Results
Serenity Pro enables the practitioner to deliver light based treatments with fewer side effects such as erythema and improved treatment outcomes. This is achieved through the removal of the competing chromophores from the treatment area creating a clear path for the light energy to be absorbed by the target chromophore only, allowing the practitioner to increase the energy levels with significantly reduced side effects.
An in-clinic live demonstration of this device is highly recommended. To arrange your demonstration contact Candela on 0845 521 0698 or e-mail Serenity@candelalaser.co.uk
5th September 2008-
CANDELA a Hot Topic at the Sk:n Annual Conference
CANDELA dominated the presentations at the 2008 Sk:n conference with 4 out of 11 presentations featuring CANDELA products. Feature presentations were the VBeam pulsed dye laser by Dr Vishal Madan MBBS (Hons) MD MRCP (UK), (Salford Royal Hospital), a comparative study between the GentleLASE Alexandrite and the Lumina IPL for results and patient satisfaction in which the GentleLASE was proven to be far superior on both accounts for hair removal a study conducted by MacKay IR et al and presented by Dr Sean Lanigan MD FRCP DCH (Consultant Dermatologist, City Hospital Birmingham; Group Medical Director at Sk:n). The GentleYAG was the focus of a customer satisfaction and efficacy study presented by Dr Sankar FRCS (ENG) FRCS (Plast), (University Hospital Leicester & Medical Director, Sk:n Leicester Clinic). The new Serenity device for pain reduction was also mentioned in a presentation by Dr Sean Lanigan (title) in a presentation looking at innovation in the market.
Source: Sk:n Annual Conference, Edgebaston Cricket Ground, 4th September.
February 2008
New VBEAM Studies at AAD
Vbeam Perfecta is considered the gold standard for treatment and the most advanced pulsed dye laser used for treatment of a wide range of vascular conditions including rejuvenation by correcting generalized red and brown discoloration, rosacea, age spots, and psoriasis.
- The December 2007 study in the Journal of Dermatologic Surgery entitled, "Use of a Novel Pulsed Dye Laser for Rapid Single-Pass Purpura-Free Treatment of Telangiectases" was designed to optimize treatment parameters for fast, effective, single pass treatment using Perfecta. Thirty patients with lesions on their noses, necks and cheeks were treated. All underwent a single treatment using the Vbeam Perfecta.
"No matter what sized vessel was treated and regardless of the treatment approach, purpura was not observed just after treatment nor was delayed purpura (even mild) reported by any patient." Observed Edward Victor Ross, MD, who commissioned the study along with Nathan S. Uebelhoer DO, and Yacov Domankevitz, PhD. "With this system, safe, effective, consistent and rapid vessel reduction was achieved." Overall the results showed approximately 70% reduction of smaller telangiectases with just one treatment session. "With the new eight-pulselet system (Vbeam Perfecta), one can achieve fluences as high as 10J/cm2 with the 10mm spot and achieve single pass clearance", commented Dr. Uebelhoer. "This is a major advantage over previous generations of PDLs."
-- The next study published in the February 2008 issue of the Journal of Dermatologic Surgery entitled, "Compression for the treatment of Epidermal Pigmented Lesions with the 595-mn Pulsed Dye Laser" investigated the effectiveness and safety of a compression technique for the treatment of epidermal pigmented lesions using the laser with no epidermal cooling. In this study by Jerome M. Garden, MD, Abnoeal D. Bakus, PhD, and Yacov Domankevitz, PhD, results showed the compression technique is safe and effective and no purpura or long-lasting side-effects were observed. Twelve patients underwent treatments using the laser with a compression handpiece and no epidermal cooling. Each subject received one to four treatments, four to six weeks apart.
"By compressing a transparent convex optical element against the skin, the blood in the superficial vessels was squeezed out and displaced from the irradiated zone, thus minimizing absorption by blood in the superficial vessels and allowing the use of shorter pulses while reducing purpura and unwanted side effects," noted Dr. Garden.
-- In another study in the Journal of Dermatologic Surgery entitled, "A Pulsed Dye Laser with a 10-mm Beam Diameter and a Pigmented Lesion Window for Purpura-Free Photorejuvenation" by Kenneth Galeckas, MD, Edward Victor Ross, MD, and Nathan S. Uebelhoer, DO, it was concluded that the laser is highly effective for two-pass, purpura-free improvement of telangiectases, pigment dyschromias, and texture. Twenty patients with skin types I to III were treated three times at three to four week intervals. In the majority of patients, greater than 90% reduction of fine telangiectasias and dark lentigines was achieved.
"With a large (10 mm) beam diameter, modified pulse structure, and compression handpiece of the Perfecta, time previously spent with two-pass treatments for telangiectases can now be redirected toward the treatment for lentigines for complete photorejuvenation encompassing vascular, pigmented and textural irregularities," said Dr. Ross.
-- The November 2007 edition of the Annals of Plastic Surgery, the "Comparison Study of Intense Pulsed Light Versus a Long-Pulse Pulsed Dye Laser in the Treatment of Facial Skin Rejuvenation" was conducted by Taro Kono, MD, William Frederick Groff, DO, Hiroyuki Sakurai, MD, Masaki Takeuchi, MD, Takashi Yamaki, MD, Kazutaka Soejima, MD, and Motohiro Nozaki, MD. The objective of the study was to compare the effectiveness of intense pulsed light versus a long-pulse pulsed dye laser (LPDL) in the treatment of facial skin rejuvenation. Ten Asian patients with Fitzpatrick skin types III-IV were enrolled in this study. In conclusion, both IPL and LPDL are effective for facial skin rejuvenation in Asians. LPDL treatment is significantly better than IPL treatment in the treatment of lentigines, and when using the LPDL with the compression technique for skin rejuvenation, fewer treatments were necessary than with the IPL.
"The use of the compression technique may allow the Vbeam to be used effectively for facial rejuvenation and with fewer treatment sessions compared with the IPL," noted Dr. Kono.
For more information log onto http://www.candelalaser.com
February 2008
New GentleLASE Studies at AAD
-- "A Randomized, Split-Face Comparison of Facial Hair Removal With the Alexandrite Laser and Intense Pulsed Light System" in the December issue 2007 of Lasers in Surgery and Medicine found GentleLASE far superior to the IPL from a scientific and patient perspective in testing for hair removal efficacy. In this randomized controlled study by D.J. McGill, MRCS (Ed),C. Hutchison, MA, E. McKenzie, BSc, E. McSherry, RGN, and I.R. Mackay, FRCS (Plast), women who typically demonstrate an increased rate of facial hair growth and whose hair is normally resistant to the usual course of treatments were studied. Six treatments were administered in this study with one, three and six month follow-ups. Researchers concluded that the alexandrite laser resulted in significantly longer hair-free intervals, a larger reduction in hair counts, and greater patient satisfaction than with the IPL.
"GentleLASE, when given the opportunity to demonstrate its full potential, outperformed the competition hands-down," Said Dr. Stephen W. Eubanks, M.D., Dermatology & Laser Center at Harvard Park in Denver, CO who has worked with GentleLASE.
The authors also concluded that the GentleLASE laser is more effective because of the specific wavelength, short pulse duration and single pulse delivery of the GentleLASE alexandrite laser, resulting in more follicular destruction than with the IPL.
The GentleLASE system is used for removing unwanted hair and pigmented lesions. Patients can experience 90 percent improvement after treatment with the GentleLASE safely and with no downtime.
-- In the December 2007 study in the Journal of Dermatologic Surgery, "Use of a Long-Pulse Alexandrite Laser in the Treatment of Superficial Pigmented Lesions", researchers wanted to test the efficacy of the variable long-pulse alexandrite laser in the treatment of superficial pigmented lesions. In this study commissioned by John Paul Trafeli, MD, Julia M. Kwan, MD, Kenneth J. Meehan Pa-C, Yacov Domankevitz, PhD, Sandra Gilbert, BS, Kenneth Malomo, BS, and Edward Victor Ross, MD, eighteen patients underwent a single treatment session using a variable pulse-width alexandrite laser. Test sites were performed using a 10-mm spot size and up to four pulse widths (3, 20, 40, 60 ms) with and without epidermal cooling. The results found that the variable pulse 755 nm wavelength is effective and safe in removing superficial pigmented lesions. Shorter pulse widths and treatment without cryogen cooling both, independently, lowered the fluence threshold for lentigo clearance.
"The GentleLASE is highly effective in clearing solar lentigines in a single pass with minimal side effects," commented Dr. Eubanks. "Patients expressed great satisfaction especially because there were few side effects, treatments were quick and there was minimal down time."
For more information log onto http://www.candelalaser.com
December 2007-
CANDELA UK shortlisted for award
The newly up and running CANDELA UK team have been shortlisted for an Award at the 2008 Aesthetic Medicine Awards. They have made a shortlist of three along with industry heavyweights Evolence and Q-Med for the category of Best marketing by a manufacturer/supplier. The award ceremony is due to take place on February 9th during the annual Aesthetic Medicine Conference in London.
Source: Aesthetic Medicine Journal, December/January 2008
1st October 2007-
CANDELA open UK office
Candela Corporation (Wayland, Mass) are delighted to be able to offer their industry leading support to the CANDELA users in the UK through the opening of a direct operation. The decision was made to further improve the CANDELA standing in the European markets and is a testament to the aesthetic industry’s confidence in the growing UK market. The direct UK office will have multi business elements with Sales, Marketing, Clinical support, Service/Technical support and administration. This will ensure that the current CANDELA users and the future CANDELA customers receive products and services at the level that has become accustomed with the company worldwide. The wide use of the CANDELA pulsed Dye laser throughout the NHS is a hallmark of the standard that CANDELA set. The product standard will be replicated throughout the other elements of the business so that CANDELA has an important role to play in the burgeoning UK aesthetic industry.
Mostyn West
Managing Director, CANDELA UK
All rights reserved © 2006